v3.22.4
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jul. 31, 2021     138,662          
Beginning balance at Jul. 31, 2021 $ 528,895   $ 139 $ 1,131,006   $ (650) $ (601,600)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     664          
Issuance of common stock upon exercise of stock options 4,871     4,871        
Issuance of common stock under the employee stock purchase plan (in shares)     109          
Issuance of common stock under the employee stock purchase plan 11,509     11,509        
Vesting of restricted stock units and other stock issuances (in shares)     1,628          
Vesting of restricted stock units and other stock issuances 1,703   $ 2 1,701        
Stock-based compensation 192,259     192,259        
Other comprehensive income (loss) (8,649)         (8,649)    
Net loss (191,221)           (191,221)  
Ending balance (in shares) at Jan. 31, 2022     141,063          
Ending balance at Jan. 31, 2022 539,367   $ 141 1,341,346   (9,299) (792,821)  
Beginning balance (in shares) at Jul. 31, 2021     138,662          
Beginning balance at Jul. 31, 2021 $ 528,895   $ 139 1,131,006   (650) (601,600)  
Ending balance (in shares) at Jul. 31, 2022 143,038   143,038          
Ending balance at Jul. 31, 2022 $ 573,300 $ (169,899) $ 143 1,590,885 $ (273,738) (25,850) (991,878) $ 103,839
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]              
Beginning balance (in shares) at Oct. 31, 2021     140,032          
Beginning balance at Oct. 31, 2021 $ 530,199   $ 140 1,225,224   (2,764) (692,401)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     277          
Issuance of common stock upon exercise of stock options 2,227     2,227        
Issuance of common stock under the employee stock purchase plan (in shares)     109          
Issuance of common stock under the employee stock purchase plan 11,509     11,509        
Vesting of restricted stock units and other stock issuances (in shares)     645          
Vesting of restricted stock units and other stock issuances 1,703   $ 1 1,702        
Stock-based compensation 100,684     100,684        
Other comprehensive income (loss) (6,535)         (6,535)    
Net loss (100,420)           (100,420)  
Ending balance (in shares) at Jan. 31, 2022     141,063          
Ending balance at Jan. 31, 2022 $ 539,367   $ 141 1,341,346   (9,299) (792,821)  
Beginning balance (in shares) at Jul. 31, 2022 143,038   143,038          
Beginning balance at Jul. 31, 2022 $ 573,300 $ (169,899) $ 143 1,590,885 $ (273,738) (25,850) (991,878) $ 103,839
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares) 224   224          
Issuance of common stock upon exercise of stock options $ 2,104     2,104        
Issuance of common stock under the employee stock purchase plan (in shares)     115          
Issuance of common stock under the employee stock purchase plan 11,410     11,410        
Vesting of restricted stock units and other stock issuances (in shares)     1,710          
Vesting of restricted stock units and other stock issuances 0   $ 2 (2)        
Stock-based compensation 216,544     216,544        
Other comprehensive income (loss) 20,813         20,813    
Net loss $ (125,615)           (125,615)  
Ending balance (in shares) at Jan. 31, 2023 145,087   145,087          
Ending balance at Jan. 31, 2023 $ 528,657   $ 145 1,547,203   (5,037) (1,013,654)  
Beginning balance (in shares) at Oct. 31, 2022     144,210          
Beginning balance at Oct. 31, 2022 431,275   $ 144 1,425,156   (37,824) (956,201)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     115          
Issuance of common stock upon exercise of stock options 1,122     1,122        
Issuance of common stock under the employee stock purchase plan (in shares)     115          
Issuance of common stock under the employee stock purchase plan 11,410     11,410        
Vesting of restricted stock units and other stock issuances (in shares)     647          
Vesting of restricted stock units and other stock issuances 0   $ 1 (1)        
Stock-based compensation 109,516     109,516        
Other comprehensive income (loss) 32,787         32,787    
Net loss $ (57,453)           (57,453)  
Ending balance (in shares) at Jan. 31, 2023 145,087   145,087          
Ending balance at Jan. 31, 2023 $ 528,657   $ 145 $ 1,547,203   $ (5,037) $ (1,013,654)